Company Quick10K Filing
MariMed
10-Q 2020-09-30 Filed 2020-11-09
10-Q 2020-06-30 Filed 2020-08-10
10-Q 2020-03-31 Filed 2020-05-28
10-K 2019-12-31 Filed 2020-04-01
10-Q 2019-09-30 Filed 2019-11-29
10-Q 2019-06-30 Filed 2019-08-09
10-Q 2019-03-31 Filed 2019-05-10
10-K 2018-12-31 Filed 2019-04-16
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-15
10-K 2017-12-31 Filed 2018-04-02
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-14
10-Q 2017-03-31 Filed 2017-05-15
10-K 2016-12-31 Filed 2017-04-17
10-Q 2016-09-30 Filed 2016-12-22
10-Q 2016-06-30 Filed 2016-12-19
10-Q 2016-03-31 Filed 2016-11-01
10-K 2015-12-31 Filed 2016-09-27
10-Q 2015-09-30 Filed 2015-11-16
10-Q 2015-06-30 Filed 2015-08-19
10-Q 2015-03-31 Filed 2015-06-22
10-K 2014-12-31 Filed 2015-06-09
10-Q 2014-09-30 Filed 2014-11-14
10-Q 2014-06-30 Filed 2014-08-14
10-Q 2014-03-31 Filed 2014-05-14
10-K 2013-12-31 Filed 2014-04-04
10-Q 2013-09-30 Filed 2013-11-14
10-Q 2013-06-30 Filed 2013-08-08
10-Q 2013-03-31 Filed 2013-05-15
10-K 2012-12-31 Filed 2013-03-28
10-Q 2012-09-30 Filed 2012-11-19
10-Q 2012-06-30 Filed 2012-08-15
10-Q 2012-03-31 Filed 2012-05-15
10-K 2011-12-31 Filed 2012-04-12
10-Q 2011-09-30 Filed 2011-11-21
8-K 2020-11-09 Earnings, Regulation FD, Exhibits
8-K 2020-10-20 Enter Agreement, Exhibits
8-K 2020-08-10 Other Events, Exhibits
8-K 2020-07-23 Other Events, Exhibits
8-K 2020-06-24 Enter Agreement, Exhibits
8-K 2020-05-12
8-K 2020-05-11
8-K 2020-02-27
8-K 2020-02-10
8-K 2020-02-06
8-K 2019-10-21
8-K 2019-09-26
8-K 2019-06-25
8-K 2019-06-05
8-K 2019-06-04
8-K 2019-05-20
8-K 2018-12-05
8-K 2018-11-07
8-K 2018-11-06
8-K 2018-06-19
8-K 2018-03-13

MariMed Financials

MRMD Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
GrowGeneration (GRWG) 182,705 29% 57.2 3% 68,417 15,626 54,349 16,008 2,341 2,923 167,194
Technovative Group (TEHG) 182,172 57% -105.6 -33% 5,191 3,101 765 437 -1,719 -1,719 181,597
Exagen (XGN) 182,113 54% -60.9 -3% 92,744 34,094 10,439 5,656 -3,141 -2,132 129,862
Soliton (SOLY) 179,964 -14.9 -130% 9,927 2,745 0 0 -12,896 -11,529 171,255
Acro Biomedical (ACBM) 177,190 10% -1,443.4 -13% 1,081 133 3,760 388 -142 -123 177,189
Energy & Technology (ENGT) 177,150 32% -1,446.0 -4% 3,954 9,029 3,101 984 -143 -122 177,039
Kraig Biocraft Laboratories (KBLB) 176,366 -99.2 -224% 899 5,504 0 0 -2,009 -1,775 176,083
American BriVision (ABVC) 175,304 97% -71.6 -38% 7,405 6,675 602 584 -2,817 -2,434 174,252
Vaneck Merk Gold Trust (OUNZ) 175,193 8.4 12% 174,523 0 0 0 20,914 20,914 175,193
Invesco DB Gold Fund (DGL) 174,116 9.8 10% 174,089 3,964 0 0 17,743 17,748 174,116
Fulcrum Therapeutics (FULC) 173,470 -2.4 -26% 115,956 13,828 0 0 -29,711 -29,711 70,781
MariMed (MRMD) 172,389 39% 23.2 -2% 137,056 54,263 40,412 15,889 -2,498 9,162 212,127
Fortem Resources (FTMR) 191,211 -119.9 -1% 143,155 18,644 0 0 -1,741 -1,603 192,221
Cure Pharmaceutical (CURR) 171,305 94% -10.1 -60% 34,029 20,673 284 266 -20,482 -16,320 165,597
FC Global Realty (FCRE) 170,563 86% -62.4 -2% 134,314 52,885 44 38 -2,748 -2,732 170,584
Applied Therapeutics (APLT) 170,485 -5.6 -75% 37,264 6,517 0 0 -27,880 -27,880 157,420
SWK Holdings (SWKH) 167,159 0% 9.7 6% 247,535 19,907 21,396 0 15,043 16,831 162,673
DOCASA (DCSA) 166,631 24% -117.8 -8% 22,047 6,626 6,454 1,527 -1,773 -1,408 165,842
Jamba (JMBA) 165,009 0% 68.1 -4% 36,654 46,912 78,265 0 -1,563 2,289 155,914
QNB (QNBC) 162,260 5.6 1% 1,245,863 1,126,878 0 0 11,939 25,390 141,473

Balance Sheet ($'000)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash11911942292138973581,578998105423371616013482185696402,8166531,2904105,0776,0274,1044,2163,530137
Accounts Receivable36501563124676437557705335069811,3261,4532,1223,1204,0205,3777,1348,66210,171
Inventory3,2504,7841,462
PP&E2,0972,1962,0252,8763,2994,4915,2798,66116,54425,95527,16931,36532,76936,26037,79840,20643,001
Assets19012240213662,1281,6523,5204,2543,7185,3885,8407,6975,82210,85015,35121,37232,20233,93845,44157,13382,96197,625133,676137,056
Accounts Payable1,5481,5332,8322,7212,8342,6333,9151,9402,1693,387
Long-Term Debt3,250020,52541,59639,875
Liabilities3496361,0531,1301,5703,4903,5805,7505,9665,6506,8397,3559,2549,1159,95910,08313,28721,19523,20523,79920,63221,19632,10350,85154,263
Stockholders' Equity-159-514-1,013-1,109-1,204-1,361-1,685-2,230-1,712-1,932-1,4501,515-1,557-55189182,793
Income Statement ($'000)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue25500000000000088961513937276146478741,4291,1511,8981,7161,5802,0833,3053,3923,51625,67311,224
Cost of Revenue11105655514352221831091391131,0493162154233984014244481,2618899131,5221,25516,7466,523
Gross Profit1540-5-5-5-5-4-13-3-5-2-2-2-95-1211280-3222984334511,0307491,4751,2683191,1942,0241,8702,2618,9274,700
R&D
SG&A404836534154495742425157461571001731122581131362053163034146113127581,0406571,8102,7532,486
Tax00000000000000000000008-6130-110975901
Net Income-98-12-99-146-182-383-172-116-85-152-132-124-6,638-526-2085,908-57-1,060-6239-7349109547-314-1,316-1,832-6,278-10,111784,723-7,300
Cash Flow ($'000)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-6-563175-611386-245274802,432-1,353-1,0721,045-1,709-6,224-16,108-1,850
Cash Investing170000074230-402-0-1,408-977-193-927-983-519-1,827-10-7,707-9,129-1,284-4,457-8,634-2,034-3,119-4,130
Cash Financing014-1404501,628-263501,5254517451,669-72821,7624,0533,11211,1191,4768,08011,2988,37018,5412,586